Abstract
Five inherited disorders of the urea cycle are now well described. These are characterised by hyperammonaemia and disordered amino-acid metabolism. The presentation is highly variable: those presenting in the newborn period usually have an overwhelming illness that rapidly progresses from poor feeding, vomiting, lethargy or irritability and tachypnoea to fits, coma and respiratory arrest. In infancy, the symptoms are less severe and more variable. Poor developmental progress, behavioural problems, hepatomegaly and gastrointestinal symptoms are usually observed. In children and adults, chronic neurological illness is characterised by behavioural problems, confusion, irritability and cyclic vomiting, which deteriorates to acute encephalopathy during metabolic stress. Arginase deficiency shows more specific symptoms, such as spastic diplegia, dystonia, ataxia and fits. All urea-cycle disorders have autosomal-recessive inheritance except ornithine carbamoyl transferase deficiency, which is X-linked.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Am PH, Hauser ER, Thomas GH et al. (1990) Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma. N Engl J Med 322: 1652–1655
Christodoulou J, Qureshi IA, McInnes RR, Clarke JT (1993) Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr 122: 423–425
Fowler GW (1979) Intermittent ataxia in heterozygote ornithine transcarbamylase deficiency. Ann Neurol 6: 185–186
Patel JS, Van’t Hoff W, Leonard JV (1994) Arginase deficiency presenting with convulsions. J Inherit Metab Dis 17: 254
Newsholme EA, Leech AR (1983) Biochemistry for the medical sciences. Wiley, Chichester, pp 491–494
Batshaw ML, Brusilow SW (1978) Asymptomatic hyperammonaemia in low birthweight infants. Pediatr Res 12: 221–224
Bachmann C, Colombo JP (1983) Increased tryptophan uptake into the brain in hyperammonaemia. Life Sci 33: 2417–2424
Hyman SL, Porter CA, Page TJ et al. (1987) Behavior management of feeding disturbances in urea cycle and organic acid disorders. J Pediatr 111: 558–562
Surtees RJ, Leonard JV (1989) Acute metabolic encephalopathy. J Inherit Metab Dis 12 [Suppl 1]:42–54
Connelly A, Cross JH, Gadian DG et al. (1993) Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 33: 77–81
Batshaw ML, Berry GT (1991) Use of citrulline as a diagnostic marker in the prospective treatment of urea cycle disorders. J Pediatr 118: 914–917
Kendall B, Kingsley DPE, Leonard JV, Lingam S, Oberholzer VG (1983) Neurological features and computed tomography of the brain in children with ornithine carbamyl transferase deficiency. J Neurol Neurosurg Psychiatr 46: 28–34
Hudak ML, Jones MD, Brusilow SW (1985) Differentiation of transient hyperammonaemia of the newborn and urea cycle enzyme defects by clinical presentation. J Pediatr 107: 712–719
Brusilow SW, Valle DL, Batshaw ML (1979) New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 11: 452–454
Feillet F, Leonard JV (1998) Alternative pathway therapy for urea cycle disorders. J Inherit Metab Dis 21 [Suppl 11: 101–111
Brusilow SW (1991) Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr Res 29: 147–150
Wiech NL, Clissold DM, MacArthur RB (1997) Safety and efficacy of buphenyl (sodium phenylbutyrate) tablets and powder (abstract). Advances in inherited urea cycle disorders, satellite to the 7th international congress for inborn errors of metabolism, Vienna, p 25
Brusilow SW (1984) Arginine, an indispensible aminoacid for patients with inborn errors of urea synthesis. J Clin Invest 74: 2144–2148
Levin B, Russell A (1967) Treatment of hyperammonaemia. Am J Dis Child 113: 142–144
Iafolla AK, Gale DS, Roe CR (1990) Citrate therapy in arginosuccinate lyase deficiency. J Pediatr 117: 102–105
Bachmann C, Colombo JP, Jaggi K (1982) N-acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observations and treatment. Adv Exp Med Biol 153: 39–45
Tripp JH, Hargreaves T, Anthony PP et al. (1981) Sodium Valproate and ornithine carbamyl transferase deficiency (letter). Lancet 1: 1165–1166
Maestri NE, McGowan KD, Brusilow SW (1992) Plasma glutamine concentration: a guide to the management of urea cycle disorders. J Pediatr 121: 259–261
Dixon MA, Leonard JV (1992) Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 67: 1387–1391
Maestri NE, Hauser ER, Bartholomew D, Brusilow SW (1991) Prospective treatment of urea cycle disorders. J Pediatr 119: 923–928
Todo S, Starzl TE, Tzakis A et al. (1992) Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 15: 419–422
Saudubray J-M, Tonati G, DeLonlay P et al. (1999) Liver transplantation in urea cycle disorders. Eur J Pediatr 158 [Suppl 2]: S55–59
Hauser ER, Finkelstein JE, Valle D, Brusilow SW (1990) Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. N Engl J Med 322: 1641–1645
Sebesta I, Fairbanks LD, Davies PM, Simmonds HA, Leonard JV (1994) The allopurinol loading test for the identification of carriers for ornithine carbamoyl transferase deficiency: studies in a healthy control population and females at risk. Clin Chim Acta 224: 45–54
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leonard, J.V. (2000). Disorders of the Urea Cycle. In: Fernandes, J., Saudubray, JM., Van den Berghe, G. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04285-4_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-04285-4_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-04287-8
Online ISBN: 978-3-662-04285-4
eBook Packages: Springer Book Archive